Norfolk research company plans clinical trials using medical marijuana
Eighteen months after receiving a broad federal license for importing medical cannabis, a Norfolk research company is about to embark on a series of critical studies into a variety of medical and mental disorders, diseases and conditions.
Sanyal Biotechnology is already considering proposals for research campuses and planning its first clinical trial for this summer. The new venture potentially opens the door to significantly expanding national research being done on the medical benefits of cannabis. Read the full story here.
Stories you may be interested in
Florida’s largest cannabis company makes a deal to carry edible marijuana products
TALLAHASSEE The state’s first and largest medical marijuana provider, Trulieve, signed an exclusive deal to bring high-end edible marijuana products to Florida, the company announced Wednesday. Binske, the Colorado-based company, began operations just two years ago, markets “an experience” through their top-shelf products. Florida’s 162,000 registered patients will soon be able to buy and medicate…
Read More 
Medical marijuana helped elderly with chronic pain and reduced their use of opioids, study found
Your grandparents’ chronic aches and pains might best be eased with a little weed, a new study suggests. Not only did folks over 75 who took medical marijuana report less pain, their use of pot-based capsules, tinctures and e-cigarettes allowed a third of these patients to reduce their use of opioid painkillers, researchers found. “Medical marijuana, in…
Read More 
Substance in cannabis ‘could boost pancreatic cancer treatments’
A substance found in cannabis plants might boost treatments for patients with pancreatic cancer, research in mice has suggested. Cannabidiol, or CBD, is not psychoactive, meaning it does not produce feelings of being high in those who take it. It is extracted from hemp plants and is legal in the UK, although a CBD product…
Read More 
A Message To Our Clients
To Our Clients, First of all, I hope everyone is staying safe and healthy in these unprecedented times. I want to assure you that Arfinn Med has systems in place to ensure that our workflows are not impacted from having staff work remotely and we will continue to provide the same quality product and customer service…
Read More 
Texas House Bill 3703: What You Need to Know
The state of Texas has been in the news in recent months as the legislature review House Bill 3703. This bill relates to “the prescription of low-THC cannabis for medical use by certain qualified physicians to patients with [specific] qualifying conditions”. Originally filed in March of 2019, this bill made its way through the house…
Read More 
Customize Your Patient Notes with Arfinn Med
Joining the text messaging update, the Arfinn Med portal now presents the ability to create note taking templates. This innovative addition will allow physicians to streamline the data and information that they are collecting from patients, resulting in their cases staying aligned and concise. Additionally, through this function, physicians will be able to pick and…
Read More